Electrochemotherapy with bleomycin in SA‐1 tumor‐bearing mice—natural resistance and immune responsiveness

Electrochemotherapy is an antitumor treatment that utilizes locally delivered electric pulses to increase the effectiveness of chemotherapeutic drugs in cells and tissues. Electric pulses permeabilize tumor cells to allow non-permeant drugs such as bleomycin to enter the cells. Although preclinical data indicate that immune responsiveness of the organism is important for obtaining cures of the tumors after electrochemotherapy with bleomycin, it is not known how electrochemotherapy affects the immune system of the organism. The aim of the study was to determine the effects of electrochemotherapy with bleomycin on natural resistance and immune responsiveness. Natural resistance was evaluated by phagocytic and intra-cellular killing activity (oxidative burst) in monocytes and polymorphonuclear granulocytes from venous blood, and immune responsiveness by blast transformation of spleen mononuclear cells to mitogens. The percentage of monocytes in venous blood able to elicit oxidative burst was significantly increased 7 days after the electrochemotherapy and returned to normal values after 14 days. In addition, increased blast transformation of spleen mono-nuclear cells by stimulation with concanavalin A (T lymphocytes activity) was found 14 days after electrochemotherapy treatment. The results of our study demonstrate that electrochemotherapy with bleomycin affects the immune system of the organism.

[1]  M J Jaroszeski,et al.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy , 1996, Cancer.

[2]  L. Mir,et al.  Antitumor electrochemotherapy: New advances in the clinical protocol , 1996, Cancer.

[3]  Damijan Miklavčič,et al.  Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice , 1996 .

[4]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.

[5]  Damijan Miklavčič,et al.  Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy , 1995 .

[6]  M. Jaroszeski,et al.  Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem , 1995 .

[7]  L. Mir,et al.  Systemic Antitumor Effects of Electrochemotherapy Combined with Histoincompatible Cells Secreting Interleukin‐2 , 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[8]  L. Mir,et al.  Electrochemotherapy: variable anti-tumor effect on different tumor models , 1994 .

[9]  L. Mir,et al.  Electrochemotherapy, a new antitumor treatment. First clinical phase I‐II trial , 1993, Cancer.

[10]  A Brun,et al.  A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. , 1993, Biochemical and biophysical research communications.

[11]  L. Mir,et al.  Cell electropermeabilization: a new tool for biochemical and pharmacological studies. , 1993, Biochimica et biophysica acta.

[12]  M. Okino,et al.  Optimal Electric Conditions in Electrical Impulse Chemotherapy , 1992, Japanese journal of cancer research : Gann.

[13]  L. Mir,et al.  Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. , 1992, European cytokine network.

[14]  L. Mir,et al.  Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. , 1991, Biochemical pharmacology.

[15]  T. Tsong,et al.  Electroporation of cell membranes. , 1991, Biophysical journal.

[16]  J Teissié,et al.  Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. , 1990, Biophysical journal.

[17]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[18]  H. Potter,et al.  Electroporation in biology: methods, applications, and instrumentation. , 1988, Analytical biochemistry.

[19]  M. Okino,et al.  Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. , 1987, Japanese journal of cancer research : Gann.

[20]  P. Seglen,et al.  Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. , 1986, European journal of cancer & clinical oncology.

[21]  D. Miklavčič,et al.  Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients , 1995 .

[22]  D. Miklavčič,et al.  Improved therapeutic effect of electro chemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice , 1995 .

[23]  J. Weaver.  Molecular basis for cell membrane electroporation. , 1994, Annals of the New York Academy of Sciences.

[24]  L. Mir,et al.  Electrochemotherapy of spontaneous mammary tumours in mice. , 1991, European journal of cancer.

[25]  L. Mir,et al.  Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.

[26]  沖野 基規.  The effects of a single high voltage electrical stimulation with an anticancer drug on in vivo growing malignant tumors , 1991 .